semaglutide if not overweight GLP-1 agonists and changes in body mass and composition in adults with or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Semaglutide - Renew Body Wellness

However, dose escalation must be balanced against tolerability, particularly gastrointestinal adverse effects such as nausea, which affect approximately 1520% of users according to clinical trials

In a trial of adult patients with type 2 diabetes and BMI greater than or equal to 27 kg/m2 for weight reduction (Study 3), diabetic retinopathy was reported by 4% of WEGOVY injection-treated patients and 2.7% placebo-treated patients [see Clinical Studies (14.2)]

M.IannantuoniF.Escribano-LpezI.Lpez-DomnechS.et al (2019)

You will learn what a beyond-use date actually means, how long your vial truly lasts under different conditions, how to spot signs of degradation before you inject, and exactly how to store your medication for maximum potency